Michelle Bradney

Michelle completed a PhD with the Department of Medicine, Melbourne University before moving into the pharmaceutical industry. She has over 25 years of progressive global clinical development, clinical operations and medical affairs experience working across Australia, Asia Pacific, Europe and USA. Michelle has worked in start-up biotechnology companies and global pharmaceutical and device companies where she has led successful IND and IDE approvals across multiple jurisdictions as well as leading their clinical programs and medical affairs operations. Michelle is the Chief Operating Officer at OccuRx and is responsible to lead and manage OccuRx’s drug development, clinical trial execution and business operations.